DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING' 
May 30-31, 1991 
The Recombinant DNA Advisory Committee (RAC) was convened for its forty-seventh 
meeting at 9:00 a.m. on May 30, 1991, in Building 31C, Conference Room 6, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. Gerard J. McGarrity 
(Chair) presided. In accordance with Public Law 92-463, the meeting was open to the public. 
The following were present for all or part of the meeting: 
Committee members: 
Ronald M. Atlas, University of Louisville 
John H. Barton, Stanford I^w School 
A1 W. Bourquin, Ecova Italia 
Michael F. Brewer, Dun and Bradstreet Corporation 
Constance E. Brinckerhoff, Dartmouth Medical School 
Nancy L. Buc, Weil, Gotshal and Manges 
Ira H. Carmen, University of Illinois 
Roy H. Doi, University of California, Davis 
E. Peter Geiduschek, University of California, San Diego 
Martin F. Gellert, National Institutes of Health 
Robert Haselkom, University of Chicago 
Susan S. Hirano, University of Wisconsin 
William N. Kelley, University of Pennsylvania Medical Center 
Donald J. Krogstad, Washington University School of Medicine 
Brigid G. Leventhal, Johns Hopkins Oncology Center 
Brian F. Mannix, Buckland Mill Associates 
Gerard J. McGarrity, Coriell Institute for Medical Research 
R. Scott Mclvor, University of Minnesota 
Barbara E. Murray, University of Texas Health Science Center 
Robert F. Murray, Jr., Howard University 
Leonard E. Post, Upjohn Company 
Moselio Schaechter, Tufts University School of Medicine 
''The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific 
issues. 
Recombinant DNA Research, Volume 14 
[607] 
